The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Health Policy
- Vol. 68 (1) , 113-121
- https://doi.org/10.1016/j.healthpol.2003.09.001
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the NetherlandsHealth Policy, 2002
- Health-Based Risk Adjustment: Is Inpatient and Outpatient Diagnostic Information Sufficient?INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 2001
- Pharmacy Costs GroupsMedical Care, 1999
- Risk-adjusted capitation payments: Developing a diagnostic cost groups classification for the Dutch situationHealth Policy, 1998
- A Chronic Disease Score with Empirically Derived WeightsMedical Care, 1995
- Risk Adjusting Community Rated Health Plan Premiums: A Survey of Risk Assessment Literature and Policy ApplicationsAnnual Review of Public Health, 1995
- Replicating the chronic disease score (CDS) from automated pharmacy dataJournal of Clinical Epidemiology, 1994
- Predictability of Individual Health Care ExpendituresJournal of Risk and Insurance, 1992
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992
- Development and Application of a Population-Oriented Measure of Ambulatory Care Case-MixMedical Care, 1991